Page last updated: 2024-10-22

beta-aminoethyl isothiourea and Ventricular Fibrillation

beta-aminoethyl isothiourea has been researched along with Ventricular Fibrillation in 1 studies

beta-Aminoethyl Isothiourea: A radiation-protective agent that can inhibit DNA damage by binding to the DNA. It also increases the susceptibility of blood cells to complement-mediated lysis.

Ventricular Fibrillation: A potentially lethal cardiac arrhythmia that is characterized by uncoordinated extremely rapid firing of electrical impulses (400-600/min) in HEART VENTRICLES. Such asynchronous ventricular quivering or fibrillation prevents any effective cardiac output and results in unconsciousness (SYNCOPE). It is one of the major electrocardiographic patterns seen with CARDIAC ARREST.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hajnal, A1
Nagy, O1
Litvai, A1
Papp, J1
Parratt, JR1
VĂ©gh, A1

Other Studies

1 other study available for beta-aminoethyl isothiourea and Ventricular Fibrillation

ArticleYear
Nitric oxide involvement in the delayed antiarrhythmic effect of treadmill exercise in dogs.
    Life sciences, 2005, Sep-02, Volume: 77, Issue:16

    Topics: Analysis of Variance; Animals; beta-Aminoethyl Isothiourea; Dog Diseases; Dogs; Hemodynamics; NG-Nit

2005